Select Page

Thursday, 19 Nov, 3:00 PM – 5:00 PM 


The global pharmaceutical industry presently relies on the pharmaceutical supply chain in India and China for the manufacture of much of the active pharmaceutical ingredients (APIs) for both generic and branded drugs. China provides almost two-thirds of the global APIs but Indian pharmaceutical companies have been found to have better capabilities in formulation development, finished drug manufacturing, and product marketing in regulated markets such as United States and Europe. The Indian pharmaceutical industry has seen revenue growth of 12% per year and the country is producing about 20% of all generics globally, second only to China. With growing efforts to reduce healthcare costs, generics are projected to represent 92% of all drugs globally by 2022. Pharmaceutical industry has come under scrutiny for the pollution resulting from drug manufacturing. In particular, the emergence of antibiotic resistant bacteria, or “superbugs,” has been attributed in part to insufficient attention to management of pharmaceutical manufacturing waste.

Since the introduction of the non-financial reporting mandate for business entities by the Government of India’s Ministry of Environment and Forests in 1993, the manufacturing landscape has changed. The regulatory framework for checking the environmental impacts of chemical-based manufacturing plants has strengthened with much of activity reported in the past decade. A thorough study of published literature revealed that the various manufacturing steps in pharmaceutical units involve a wide variety of chemical syntheses. These processes are associated with large amounts of energy consumption causing high green-house gas (GHG) emissions and waste generation. Accordingly, a comparative analysis, through an exploratory study of the trends followed in India and in other countries has been reported.

This webinar will provide an overview of adopting green and sustainable practices in biopharma sector.


–  Need for Sustainable Practices in Research and Manufacturing
–  Successful Green Chemistry & Engineering Technologies and Green Process Development
–  Opportunities, Realities, Challenges and Strategies in Adapting Green and Sustainable Practices
–  Sharing Best Practices from Biopharma Industry


1. Dr. Santosh Noronha, Department of Chemical Engineering, Indian Institute of Technology, Bombay
2. Dr. Rakeshwar Bandichhor, Head, Chemistry – API – Process R&D, Dr. Reddy’s Laboratories
3. Dr. Nitesh H. Mehta, Convenor of Industrial Green Chemistry World and Director, Newreka Green Synth Technologies Pvt. Ltd
4. Dr. S. Ganesh, Chief Scientific Officer, Anthem Biosciences

Webinar/Workshop organized by: nbm

iSeekh Disclaimer

We list events as per details provided by the organizer. We are NOT responsible or liable in case of any non-availability or deficiency of the service provided, including any paid event/services.